Xtandi 40 MG capsule 120S
Ended Awarded Last action
- Contract number
- SPE2DR26FHGV4
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $12,766
Award facts
- Contract value 100% obligated
- $12,766.02 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order valued at $12,766.02 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler headquartered in Park Ridge, Illinois, for the supply of Xtandi 40 mg capsules (120-count packages). This firm fixed-price delivery order, issued on December 20, 2025, with an ultimate completion date of December 22, 2025, was awarded without set-aside designation, demonstrating the contractor's competitive capability in unrestricted federal procurement. The award is issued under DMS Pharmaceutical Group's single-award Indefinite Delivery Contract (IDC) with the Defense Logistics Agency's Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V) initiative, designated as contract SPE2DR, which was established on November 13, 2025, with a $499.999 billion ceiling and completion date of December 31, 2036.
As a critical regional prime vendor contractor within the $30.3 billion PPV-G GEN V acquisition strategy, DMS Pharmaceutical Group supplies a comprehensive range of pharmaceutical products including branded and generic prescription medications, biologics, vaccines, and specialty pharmaceuticals to support Department of Defense military healthcare facilities worldwide. The contractor's selection under this strategic contracting vehicle reflects its demonstrated performance in fulfilling the diverse pharmaceutical requirements of the federal military medical system, with delivery orders historically ranging from nominal purchases to awards exceeding $115,000 across multiple therapeutic categories and product lines.
Quick answers
Who was awarded contract SPE2DR26FHGV4?
SPE2DR26FHGV4 was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on December 20, 2025.
How much is contract SPE2DR26FHGV4 worth?
The government has obligated $12,766 on SPE2DR26FHGV4.
Is contract SPE2DR26FHGV4 an order under another contract?
Yes. SPE2DR26FHGV4 is a delivery order under SPE2DR25D9244, an indefinite delivery contract.
Was contract SPE2DR26FHGV4 competed?
The extent of competition for SPE2DR26FHGV4 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award